Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
Over the past 50 years, breast cancer immunotherapy has emerged as an active field of research, generating novel, targeted treatments for the disease. Immunotherapies carry enormous potential to improve survival in breast cancer, particularly for the subtypes carrying the poorest prognoses. Here, we...
Guardado en:
Autores principales: | Chiara Cilibrasi, Panagiotis Papanastasopoulos, Mark Samuels, Georgios Giamas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b3b25a1781634d50a5f35e21acee8ac2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
por: Silvia Jiménez-Morales, et al.
Publicado: (2021) -
Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
por: Xupeng Bai, et al.
Publicado: (2021) -
Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Alessandro Allegra, et al.
Publicado: (2021) -
Histamine in cancer immunology and immunotherapy. Current status and new perspectives
por: María de la Paz Sarasola, et al.
Publicado: (2021) -
Stimuli-Responsive Polymeric Nanomaterials for the Delivery of Immunotherapy Moieties: Antigens, Adjuvants and Agonists
por: Raveena Nagareddy, et al.
Publicado: (2021)